Dermatofibrosarcoma protuberans: A clinicopathological analysis of 10 cases in Asians

Australasian Journal of Dermatology

Volumn 45, Issue 1, 2004, Pages 29-33

  Tan, Audrey W H ^a   Tan, Suat Hoon ^a  

^a NATIONAL SKIN CENTRE   (Singapore)

Author keywords

Bednar tumour; CD34; Cutaneous neoplasm; Dermatofibroma; Fibrosarcoma; Spindle cells; Storiform arrangement

Indexed keywords

CD34 ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ASIAN; CANCER INVASION; CANCER LOCALIZATION; CANCER RECURRENCE; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; DERMATOFIBROSARCOMA PROTUBERANS; DISEASE DURATION; EXCISION; FEMALE; FIBROSARCOMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDIAN; MALE; OUTCOMES RESEARCH; REVIEW; SPINDLE CELL;

ADOLESCENT; ADULT; ANTIGENS, CD34; ASIAN CONTINENTAL ANCESTRY GROUP; DERMATOFIBROSARCOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SINGAPORE; SKIN NEOPLASMS;

EID: 1542314392     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2004.00048.x     Document Type: Review

References (19)

1. Mackie RM. Soft tissue tumours. In: Champion RH, Burton JL, Burns DA, Breathnach SM (eds). Textbook of Dermatology, Vol. 3, 6th edn. Oxford: Blackwell Science, 1998; 2547-72.
2. Haycox CL, Odland PB, Olbricht SM, Piepkorn M. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment. J. Am. Acad Dermatol. 1997; 37: 458-44.
3. Taylor HB, Helwig EB. Dermatofibrosarcoma protuberans. A study of 115 cases. Cancer 1962; 15: 717-25.
4. McPeak CJ, Cruz T, Nicastri AD. Dermatofibrosarcoma protuberans. An analysis of 86 cases - five with metastasis. Ann. Surg. 1967; 166: 803-16.
5. Land and people. In: Foo SL, Ali Z, Yahya NR (eds). Singapore Facts and Pictures 2002. Singapore: Ministry of Information, Communication and the Arts, 2002; 8.
6. Diaz-Cascajo C, Weyers W, Borrego L, Inarrea JB, Borghi S. Dermatofibrosarcoma protuberans with fibrosarcomatous areas: A clinico-pathologic and immunohistochemic study in four cases. Am. J. Dermatopathol. 1997; 19: 562-7.
7. Mentzel T, Beham A, Katenkamp D, Dei Tos AP, Fletcher CD. Fibrosarcomatous ('high-grade') dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am. J. Surg. Pathol. 1998; 22: 576-87.
8. Connelly JH, Evans HL. Dermatofibrosarcoma protuberans. A clinicopathologic review with emphasis on fibrosarcomatous areas. Am. J. Surg. Pathol. 1992; 16: 921-5.
9. Ding J, Hashimoto H, Enjoji M. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. A clinicopathologic study of nine cases and a comparison with allied tumours. Cancer 1989; 64: 721-9.
10. Dupree WB, Langloss JW, Weiss SW. Pigmented dermatofibrosarcoma protuberans (Bednar tumour). A pathologic, ultrastructural and immunohistochemical study. Am. J. Surg. Pathol. 1985; 9: 630-9.
11. Zelger B, Sidoroff A, Stanzl U, Fritsch PO, Ofner D, Zelger B, Jasani B, Schmid KW. Deep penetrating dermatofibroma versus dermatofibrosarcoma protuberans: a clinicopathologic comparison. Am. J. Surg. Pathol. 1994; 18: 677-86.
12. Kamino H, Jacobson M. Dermatofibroma extending into the subcutaneous tissue. Differential diagnosis from dermatofibrosarcoma protuberans. Am. J. Surg. Pathol. 1990; 14: 1156-64.
13. Alba S, Tabata N, Ishii H, Ootani H, Tagami H. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34. Br. J. Dermatol. 1992; 127: 79-84.
14. Abenoza P, Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am. J. Dermatopathol. 1993; 15: 429-34.
15. Goldblum JR. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans. Arch. Pathol. Lab. Med. 1995; 119: 238-41.
16. Gloster HM Jr. Dermatofibrosarcoma protuberans. J. Am. Acad. Dermatol. 1996; 35: 355-74.
17. Nouri K, Lodha R, Jimenez G, Robins P. Mohs micrographic surgery for dermatofibrosarcoma protuberans: University of Miami and NYU experience. Dermatol. Surg. 2002; 28: 1160-4.
18. Ah-Weng A, Marsden JR, Sanders DS, Waters R. Dermatofibrosarcoma protuberans treated by micrographic surgery. Br. J. Cancer 2002; 87: 1386-9.
19. Prieto VG, Reed JA, Shea CR. CD34 immunoreactivity distinguishes between scar tissue and residual tumour in reexcisional specimens of dermatofibrosarcoma protuberans. J. Cutan. Pathol. 1994; 21: 324-9.